Severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes

JL Jacobs, W Bain, A Naqvi, B Staines… - Clinical Infectious …, 2022 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA
(vRNA) is detected in the bloodstream of some patients with coronavirus disease 2019 …

[HTML][HTML] SARS-CoV-2 viremia is associated with COVID-19 severity and predicts clinical outcomes.

JL Jacobs, W Bain, A Naqvi, B Staines, P Castanha… - 2021 - dukespace.lib.duke.edu
Background SARS-CoV-2 viral RNA (vRNA) is detected in the bloodstream of some patients
with COVID-19 (" RNAemia") but it is not clear whether this RNAemia reflects viremia (ie …

Severe acute respiratory syndrome coronavirus 2 RNA in serum as predictor of severe outcome in coronavirus disease 2019: a retrospective cohort study

K Hagman, M Hedenstierna… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19). This study aimed to determine if SARS-CoV-2 RNA …

High frequency of SARS-CoV-2 RNAemia and association with severe disease

CA Hogan, BA Stevens, MK Sahoo… - Clinical Infectious …, 2021 - academic.oup.com
Background Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
RNA in blood, also known as RNAemia, has been reported, but its prognostic implications …

Relationship between serum severe acute respiratory syndrome coronavirus 2 nucleic acid and organ damage in coronavirus 2019 patients: a cohort study

D Xu, F Zhou, W Sun, L Chen, L Lan, H Li… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread
worldwide and has the ability to damage multiple organs. However, information on serum …

[HTML][HTML] SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus

MI Andersson, CV Arancibia-Carcamo… - Wellcome open …, 2020 - ncbi.nlm.nih.gov
Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses
PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been …

RNAemia corresponds to disease severity and antibody response in hospitalized COVID-19 patients

KA Eberhardt, C Meyer-Schwickerath, E Heger… - Viruses, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents a global health
emergency. To improve the understanding of the systemic component of SARS-CoV-2, we …

Quantitative assessment of SARS‐CoV‐2 RNAemia and outcome in patients with coronavirus disease 2019

K Tang, L Wu, Y Luo, B Gong - Journal of Medical Virology, 2021 - Wiley Online Library
The disease spectrum of coronavirus disease 2019 (COVID‐19) varies from asymptomatic
infection to critical illness and death. Identification of prognostic markers is vital for predicting …

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

L Colagrossi, M Antonello, S Renica, M Merli… - BMC Infectious …, 2021 - Springer
Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated
with worse COVID-19 outcome. However, whether specific population can be at higher risk …

SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19

H Kawasuji, Y Morinaga, H Tani… - Journal of Medical …, 2022 - Wiley Online Library
This study aimed to determine the frequency of SARS‐CoV‐2 RNA in serum and its
association with the clinical severity of COVID‐19. This retrospective cohort study performed …